Multiple myeloma protein with three light chains

Area of Science:

• Immunology
• Oncology
• Biochemistry

Background:

• Multiple myeloma is a cancer of plasma cells, often characterized by the overproduction of a single type of immunoglobulin (M-protein).
• Kappa and lambda are the two types of immunoglobulin light chains, and their imbalance can indicate underlying plasma cell disorders.

Observation:

• A patient with immunoglobulin G (kappa) myeloma presented with both a monoclonal IgG(kappa) arc and excess free kappa light chains in the serum.
• Urine analysis revealed significant excretion of kappa chains (7.75 g/L).

Findings:

• Immunoelectrophoresis and immunodiffusion identified an electrophoretically fast-moving kappa chain in the serum as a complex of kappa light chains and alpha 1-antitrypsin.
• This kappa chain-alpha 1-antitrypsin complex was transient and formed via a disulfide bond between monomeric kappa chains and alpha 1-antitrypsin.
• The formation of this complex appears linked to kappa-type myeloma protein and high urinary kappa chain levels (>1 g/L).

Implications:

• This transient complex represents a novel biochemical finding in certain myeloma cases, potentially serving as a diagnostic or prognostic marker.
• Further research is needed to elucidate the predisposing factors for complex formation and its relationship with myeloma treatment (chemotherapy).